Article Details
Retrieved on: 2024-02-08 17:57:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PHOENIX, February 08, 2024--MIVI Neuroscience™ announces results of the EvaQ Trial with primary effectiveness endpoint showing revasc rates of ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here